鈴木　佳代　業績集

英文業績（2016年から現在まで）

IF (impact factor)：　2023年ISI Journal Citation Reportsより

 

本数

ＩＦ合計

一編あたり

First author

9

18.6

2.1

Corresponding author

0

0.000

0.000

Second author

0

0.000

0.000

その他

12

17.6

1.5

英文全業績

21

35.6

1.7

 

  1. Watanabe D, Namba K, Hase K, Suzuki K, Ogino Y, Saito M, Iwata D, Mizuuchi K, Hiraoka M, Narita M, Kitaichi N, Kitaya N, Ishida S. Acute retinal necrosis during the systemic use of Janus kinase inhibitor. Int J Retina Vitr. 2025; 11: 135
  2. Nakai S, Takeuchi M, Usui Y, Namba K, Suzuki K, Harada Y, Kusuhara S, Kaburaki T, Tanaka R, Takeuchi M, Mizuki N, Nakai K, Goto H, Herbort CP Jr. Efficacy and Safety of Adalimumab for Exacerbation or Relapse of Ocular Inflammation in Patients with Vogt-Koyanagi-Harada Disease: A Multicenter Study. Ocul Immunol Inflamm. 2024; 32, 367-375
  3. Arita T, Namba K, Iwata D, Suzuki K, Ogino Y, Mizuuchi K, Hiraoka M, Kitaichi N, Ishida S. A case of tubulointerstitial nephritis and uveitis syndrome accompanied by subclinical choroiditis. BMC Ophthalmol. 2023; 23, 424
  4. Ogino Y, Namba K, Iwata D, Suzuki K, Mizuuchi K, Hiraoka M, Kitaichi N, Ishida S. A case of APMPPE-like panuveitis presenting with extensive outer retinal layer impairment following COVID-19 vaccination. BMC Ophthalmol. 2023; 23, 233
  5. Shinagawa M, Namba K, Mizuuchi K, Iwata D, Hase K, Suzuki K, Hirooka K, Kitaichi N, Hiraoka M, Ishida S. The Steroid-Sparing Effect of Adalimumab in the Treatment for the Recurrent Phase of Vogt-Koyanagi-Harada Disease. Ocul Immunol Inflamm. 2023; 31, 501-505
  6. Suzuki K, Iwata D, Namba K, Hase K, Hiraoka M, Murata M, Kitaichi N, Foxton R, Ishida S. Involvement of Angiopoietin 2 and vascular endothelial growth factor in uveitis. PLoS One. 2023; 18, e0294745
  7. Suzuki K, Shinmei Y, Hirooka K, Kanaya R, Shinkai A, Kijima R, Chin S, Ito YM, Ishida S. Reduction of Intraocular Pressure and Aqueous Outflow Resistance After Modified 360-degree Suture Trabeculotomy. J Glaucoma. 2023; 32, 204-209
  8. Fukutsu K, Kase S, Iwata D, Suzuki K, Namba K, Ishida S. The Expression of Matrix Metalloproteinases in Eyes with Intraocular Lymphoma. Ocul Immunol Inflamm. 2022; 30, 1798-1802
  9. Kase S, Namba K, Iwata D, Mizuuchi K, Suzuki K, Ito T, Hase K, Kitaichi N, Ishida, S. Diagnostic Accuracy of Cell Block Preparations and Clinical Features Affecting It in Vitreoretinal Lymphoma. J Clin Med. 2022; 11
  10. Suzuki K, Ishihara M, Namba K, Ohno S, Goto H, Takase H, Kawano S, Shibuya E, Hase K, Iwata D, Mizuuchi K, Kitaichi N, Mizuki N, Ishida S. Clinical features of ocular sarcoidosis: severe, refractory, and prolonged inflammation. Jpn J Ophthalmol. 2022; 66, 447-454
  11. Suzuki K, Namba K, Hase K, Mizuuchi K, Iwata D, Ito T, Kitaichi N, Takase H, Ishida S. A case of Epstein-Barr virus acute retinal necrosis successfully treated with foscarnet. Am J Ophthalmol Case Rep. 2022; 25, 101363
  12. Suzuki K, Namba K, Kase S, Ogino Y, Hase K, Iwata D, Mizuuchi K, Hiraoka M, Kitaichi N, Ishida S. Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma. BMC Ophthalmol. 2022; 22, 428
  13. Takeuchi M, Nakai S, Usui Y, Namba K, Suzuki K, Harada Y, Kusuhara S, Kaburaki T, Tanaka R, Mizuki N, Nakai K, Goto H, Herbort CP Jr. Adalimumab treatment for chronic recurrent Vogt-Koyanagi-Harada disease with sunset glow fundus: A multicenter study. Saudi J Ophthalmol. 2022; 36, 380-386
  14. Weng X, Iwata D, Namba K, Suzuki K, Mizuuchi K, Nakamura H, Atsumi T, Ishida S. Posterior scleritis with anti-neutrophil cytoplasmic antibody-associated vasculitis utilizing rituximab therapy to maintain remission: A case report. Am J Ophthalmol Case Rep. 2022; 25, 101333
  15. Yokoi K, Namba K, Iwata D, Mizuuchi K, Hase K, Suzuki K, Ando R, Hirooka K, Sekine N, Kitaichi N, Hiraoka M, Ishida S. Fundus autofluorescence imaging in acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol Case Rep. 2022; 28, 101732
  16. Fukutsu K, Namba K, Iwata D, Mizuuchi K, Kase S, Suzuki K, Shimizu H, Shibata Y, Yamawaki F, Onozawa M, Ishida S. Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging. BMC Ophthalmol. 2021; 20, 94
  17. Kase S, Namba K, Iwata D, Mizuuchi K, Ito T, Hase K, Suzuki K, Onozawa M, Kitaichi N, Ishida S. Clinical Features of Primary Vitreoretinal Lymphoma: A Single-center Study. Cancer Diagn Progn. 2021; 1, 69-75
  18. Suzuki K, Namba K, Mizuuchi K, Iwata D, Ito T, Hase K, Kitaichi N, Ishida S. Development of cytomegalovirus retinitis after negative conversion of cytomegalovirus antigenemia due to systemic antiviral therapy. Graefes Arch Clin Exp Ophthalmol. 2021; 259, 971-978
  19. Suzuki K, Namba K, Mizuuchi K, Iwata D, Ito T, Hase K, Kitaichi N, Ishida S. Validation of systemic parameters for the diagnosis of ocular sarcoidosis. Jpn J Ophthalmol. 2021; 65, 191-198
  20. Suzuki K, Baad-Hansen L, Svensson P. Verbal instructions influence pain thresholds assessment: A study using manual and electronic mechanical stimulators. Eur J Pain. 2017; 21, 900-906
  21. Suzuki K, Baad-Hansen L, Pigg M, Svensson P. Assessment of Mechanical Pain Thresholds in the Orofacial Region: A Comparison Between Pinprick Stimulators and Electronic Von Frey Device. J Oral Facial Pain Headache. 2016; 30, 338-345